Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease (Q40393362)

20 September 2017

title

Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease (English)

1 reference

20 September 2017

Wu TC

1

1 reference

20 September 2017

Leu HB

2

1 reference

20 September 2017

Lin WT

3

1 reference

20 September 2017

Lin CP

4

1 reference

20 September 2017

Lin SJ

5

1 reference

20 September 2017

Chen JW

6

1 reference

20 September 2017

publication date

1 September 2005

1 reference

European Journal of Clinical Investigation

20 September 2017

published in

1 reference

20 September 2017

volume

35

1 reference

20 September 2017

issue

9

1 reference

20 September 2017

page(s)

537-545

1 reference

Reactive oxygen species, metalloproteinases, and plaque stability

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01548.X

Matrix metalloproteinases and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01548.X

Metalloproteinases and their inhibitors in matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01548.X

Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01548.X

The stromelysin-1 5A/6A promoter polymorphism is a disease marker for the extent of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01548.X

Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01548.X

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01548.X

Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01548.X

Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01548.X

Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01548.X

Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01548.X

Nitroglycerin upregulates matrix metalloproteinase expression by human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01548.X

Relation of matrix-metalloproteinase 3 found in coronary lesion samples retrieved by directional coronary atherectomy to intravascular ultrasound observations on coronary remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01548.X

10.1111/J.1365-2362.2005.01548.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference